SMS PHARMACEUTICALS
|
The Current P/E Ratio of SMS PHARMACEUTICALS is 44.97.
| Share Price | ₹498.7 | Nov 06,2026 |
| Market Cap | ₹4,672.8 Cr | |
| Earnings-TTM | ₹103.9 Cr | TTM-Consolidated Results |
| Price/Earnings | 44.97x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SMS PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹4,672.8 Cr] as on Nov 06,2026
(/) Earnings [ ₹103.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 44.97x ]
Thus, for SMS PHARMACEUTICALS , the investors are currently willing to pay 44.97 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SMS PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SMS PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of SMS PHARMACEUTICALS
PE Ratio Performance Analysis for SMS PHARMACEUTICALS
- SMS PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 20.94x.
- SMS PHARMACEUTICALS 's operated at median p/e ratio of 27.27x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SMS PHARMACEUTICALS 's p/e ratio peaked in Mar2026 at 34.41x.
- SMS PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does SMS PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SMS PHARMACEUTICALS | 103.92 | 44.97 | 4,672.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,037.20 | 40.43 | 446,276.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 93.53 | 273,565.0 |
| TORRENT PHARMACEUTICALS LTD | 2,099.00 | 85.91 | 180,332.0 |
| CIPLA LTD | 2,868.29 | 39.69 | 113,831.0 |
| DR REDDYS LABORATORIES LTD | 2,759.70 | 41.50 | 114,532.0 |
| MANKIND PHARMA LTD | 2,249.69 | 46.63 | 104,913.0 |
| LUPIN LTD | 5,221.47 | 17.43 | 91,001.3 |
| ZYDUS LIFESCIENCES LTD | 4,159.00 | 28.66 | 119,202.0 |
| AUROBINDO PHARMA LTD | 3,993.05 | 25.89 | 103,395.0 |
| LAURUS LABS LTD | 1,333.75 | 94.59 | 126,163.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SMS PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.43x |
| Max industry PE | 94.59x |
| Median industry PE | 41.50x |
| Average industry PE | 50.84x |
You may also like the below Video Courses